Li H - Search Results

1

Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.

Wu C, Liu Y, Yang Y, Zhang P, Zhong W, Wang Y, Wang Q, Xu Y, Li M, Li X, Zheng M, Chen L, Li H. Wu C, et al. Among authors: li x, li h, li m. Acta Pharm Sin B. 2020 May;10(5):766-788. doi: 10.1016/j.apsb.2020.02.008. Epub 2020 Feb 27. Acta Pharm Sin B. 2020. PMID: 32292689 Free PMC article.

2

Furin: A Potential Therapeutic Target for COVID-19.

Wu C, Zheng M, Yang Y, Gu X, Yang K, Li M, Liu Y, Zhang Q, Zhang P, Wang Y, Wang Q, Xu Y, Zhou Y, Zhang Y, Chen L, Li H. Wu C, et al. Among authors: li h, li m. iScience. 2020 Oct 23;23(10):101642. doi: 10.1016/j.isci.2020.101642. Epub 2020 Oct 5. iScience. 2020. PMID: 33043282 Free PMC article.

3

Discovery of an Orally Active Small-Molecule Tumor Necrosis Factor-α Inhibitor.

Sun W, Wu Y, Zheng M, Yang Y, Liu Y, Wu C, Zhou Y, Zhang Y, Chen L, Li H. Sun W, et al. Among authors: li h. J Med Chem. 2020 Aug 13;63(15):8146-8156. doi: 10.1021/acs.jmedchem.0c00377. Epub 2020 Jul 30. J Med Chem. 2020. PMID: 32667202

4

Proteolysis-targeting chimera molecules targeting SHP2.

Yu D, Zheng M, Liu Y, Chen L, Li H. Yu D, et al. Among authors: li h. Future Med Chem. 2022 Apr;14(8):587-600. doi: 10.4155/fmc-2021-0324. Epub 2022 Mar 17. Future Med Chem. 2022. PMID: 35297283 Review.

5

Checkpoint-modulating immunotherapies in tumor treatment: Targets, drugs, and mechanisms.

Sun L, Chen L, Li H. Sun L, et al. Among authors: li h. Int Immunopharmacol. 2019 Feb;67:160-175. doi: 10.1016/j.intimp.2018.12.006. Epub 2018 Dec 12. Int Immunopharmacol. 2019. PMID: 30553199 Review.

6

Progress in the discovery of naturally occurring anti-diabetic drugs and in the identification of their molecular targets.

He JH, Chen LX, Li H. He JH, et al. Among authors: li h. Fitoterapia. 2019 Apr;134:270-289. doi: 10.1016/j.fitote.2019.02.033. Epub 2019 Mar 3. Fitoterapia. 2019. PMID: 30840917 Review.

7

Physapubescin I from husk tomato suppresses SW1990 cancer cell growth by targeting kidney-type glutaminase.

Yang KY, Wu CR, Zheng MZ, Tang RT, Li XZ, Chen LX, Li H. Yang KY, et al. Among authors: li xz, li h. Bioorg Chem. 2019 Nov;92:103186. doi: 10.1016/j.bioorg.2019.103186. Epub 2019 Aug 12. Bioorg Chem. 2019. PMID: 31465967

8

Structure based discovery of novel hexokinase 2 inhibitors.

Liu Y, Li M, Zhang Y, Wu C, Yang K, Gao S, Zheng M, Li X, Li H, Chen L. Liu Y, et al. Among authors: li x, li h, li m. Bioorg Chem. 2020 Mar;96:103609. doi: 10.1016/j.bioorg.2020.103609. Epub 2020 Jan 21. Bioorg Chem. 2020. PMID: 32007722

9

Natural Products and Derivatives Targeting at Cancer Energy Metabolism: A Potential Treatment Strategy.

Wang QQ, Li MX, Li C, Gu XX, Zheng MZ, Chen LX, Li H. Wang QQ, et al. Among authors: li c, li h, li mx. Curr Med Sci. 2020 Apr;40(2):205-217. doi: 10.1007/s11596-020-2165-5. Epub 2020 Apr 26. Curr Med Sci. 2020. PMID: 32337682 Review.

10

Targeting SHP2 as a therapeutic strategy for inflammatory diseases.

Liu Y, Yang X, Wang Y, Yang Y, Sun D, Li H, Chen L. Liu Y, et al. Among authors: li h. Eur J Med Chem. 2021 Mar 15;214:113264. doi: 10.1016/j.ejmech.2021.113264. Epub 2021 Feb 6. Eur J Med Chem. 2021. PMID: 33582386 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120,269 results

Search Page

Filters